Jiuzhitang Co., Ltd. (000989.SZ) has a MoatMap StockRank of 88/100 based on Quality (70/100), Value (55/100), and Momentum (48/100) factor scores. The current signal is STRONG BUY. Jiuzhitang is a traditional Chinese medicine manufacturer. While it has a stable domestic brand, it lacks global scalability, pricing power, and alignment with our high-conviction macro themes.
Jiuzhitang Co., Ltd. manufactures and distributes Traditional Chinese Medicine (TCM) products, including OTC and prescription drugs. The company possesses a centuries-old heritage brand with high consumer trust and a strong portfolio of classic TCM formulas. It is a highly respected, brand-driven TCM leader with a well-established national distribution network.
| Price | $1.15 |
| Market Cap | $1.0B |
| P/E (TTM) | 24.94 |
| P/E (Forward) | 12.67 |
| Price/Book | 1.75 |
| Return on Equity | 8.1% |
| Return on Invested Capital | 7.3% |
| Debt/Equity | 2.12 |
| Gross Margin | 59.9% |
| Operating Margin | 23.9% |
| Revenue Growth | 20.8% |
| Dividend Yield | 3.8% |
| Free Cash Flow | $8M |
Jiuzhitang Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).